Patients with Parkinson’s Disease May Have Lower Risk of Heart Attack Patients with Parkinson’s Disease May Have Lower Risk of Heart Attack Atcor_Logo_30hPatients with Parkinson’s Disease May Have Lower Risk of Heart Attack 
  • Solutions
    • Clinical Trials
      • Overview
      • Hypertension
      • Renal Disease
      • Heart Failure
      • Cognitive Impairment
      • Diabetes
      • COPD
    • Research
    • Clinical Practice
  • Technology
    • NcBP
    • SphygmoCor®
    • Oscar 2 With SphygmoCor® Inside
    • Arty Heart Health – TicWatch GTH Pro
      • Arty Heart Health Platform
      • Watching Your Heart Health
      • Visit GTH Pro
      • Buy GTH Pro Now
  • Resources
    • Publications
    • Case Studies
    • Newsletter
    • Videos
    • Webinars
    • White Papers
  • Customers
    • Register
    • Customer Log-in
  • About
    • Overview
    • Intellectual Property
    • News & Media
    • ASX Announcements
  • Blog
  • Contact
    • Contact Us
    • Technical support

Patients with Parkinson’s Disease May Have Lower Risk of Heart Attack 

Published by Amy Synnott on April 5, 2023
Elderly couple kissing

In honor of Parkinson’s disease awareness month, we wanted to cast a spotlight on a potential silver lining of this devastating illness: It may lower the risk of cardiovascular disease. By monitoring digital vascular biomarkers with SphygmoCor arterial waveform analysis, clinicians and researchers have sought to better understand the health implications of many chronic diseases, including Parkinson’s. An elevated augmentation index (Alx) or pulse pressure (PP) is strongly associated with an increased risk of an adverse cardiovascular event, such as death due to a stroke. Investigators of a 2017 publication in the Journal of Movement Disorders focused on the prevalence of heart attack and other CV events in patients with PD. The study found that peripheral and central pulse pressure was significantly lower in the Parkinson’s group than in the control group, which suggests that patients with PD are actually at lower risk of a cardiovascular event when compared to healthy individuals with a higher PP.  

Hemodynamic Indexes of Study Group Versus Control

Source: Park JH, Han SW, Baik JS. A Comparative Study of Central Hemodynamics in Parkinson’s Disease. J Mov Disord. 2017 Sep;10(3):135-139. doi: 10.14802/jmd.17035. Epub 2017 Aug 31. PMID: 28851210; PMCID: PMC5615173.

Share

Related posts

blueberries can improve heart health

Blueberries contain a high concentration of anthocyanins, powerful polyphenols that improve vascular functioning.

April 14, 2023

Can a Daily Cup of Blueberries Improve Arterial Stiffness?


Read more
April 5, 2023

Diversity in FDA Clinical Trials Gets a Boost From New Legislation 


Read more
April 5, 2023

Neighborhood Impacts on Healthcare Disparities


Read more
Sign up for our VITALITY newsletter

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: ATCOR, 184 Shuman Blvd, Naperville, IL, 60563, http://www.atcormedical.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

You can unsubscribe at any time

Subscribe

AtCor Icon

Solutions
Clinical Trials
 - Hypertension
 - Renal Disease
 - Heart Failure
 - Cognitive Impairment
 - Diabetes
 - COPD
Research
Clinical Practice

Technology
NcBP
SphygmoCor®
Oscar 2 With SphygmoCor® Inside

Resources
Publications
Case Studies
Newsletter
Videos
Webinars
White Papers
About
Overview
Intellectual Property
News & Media
ASX Announcements

Blog

Privacy Policy
Disclaimer
Acceptable Use Policy
Contact Us
Technical Support
Contact Us


+1 (630) 228-8871

[email protected]

[email protected]

The Cardiex group of companies is pleased to be a member of these esteemed professional organizations.
Copyright © 2023 ATCOR. All Rights Reserved.

    Software Downloads – Quick Descriptions

    XCEL Installation Package V1.3

    XCEL V1.3 is the latest ATCOR release of the base XCEL software.  It is a required installation for all clinical practice, academic research, and clinical trials.


    XCEL Secure Data Option Installation Package 

    XCEL Secure Data Option software enables Part11 readiness for clinical practice, academic research, and clinical trials.  Prior to install, confirm that the XCEL V1.3 software is fully installed prior to the XCEL Secure Installation Package. Contact Us for more information.


    Calibration Kit Software

    For customers who have the XCEL calibration kit, this software is used for the annual calibration of the SphygmoCor XCEL.  The SphygmoCor XCEL Calibration Kit, sold separately, is required for this calibration procedure.